JANUX THERAPEUTICS INC (JANX) Stock Earnings & Estimates
USA - NASDAQ:JANX - US47103J1051 - Common Stock
27.35 USD
+2.45 (+9.84%)
28 USD
+0.65 (+2.38%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.61M 136.54% | 8.083M -6.12% | 10.588M 30.99% | 2.924M -72.38% | 5.553M 89.91% | 5.285M -4.83% | 42.682M 707.61% | 199.54M 367.50% | 570.01M 185.66% | 1.04B 82.45% | 1.309B 25.87% | |
| EBITDA YoY % growth | -66.25M -101.86% | -71.024M -7.21% | -96.787M -36.27% | -175.994M -81.84% | -202.11M -14.84% | -270.81M -33.99% | -257.264M 5.00% | -255.439M 0.71% | 23.389M 109.16% | 251.73M 976.28% | 350.39M 39.19% | |
| EBIT YoY % growth | -67.09M -103.74% | -72.979M -8.78% | -98.847M -35.45% | -179.548M -81.64% | -228.541M -27.29% | -264.425M -15.70% | -282.838M -6.96% | -207.794M 26.53% | 36.559M 117.59% | 300.92M 723.11% | 413.99M 37.57% | |
| Operating Margin | -779.21% | -902.87% | -933.58% | -6,140.48% | -4,115.64% | -5,003.31% | -662.66% | -104.14% | 6.41% | 28.93% | 31.63% | |
| EPS YoY % growth | -1.52 -19.43% | -1.34 11.84% | -1.28 4.48% | -2.33 -82.30% | -3.09 -32.29% | -3.82 -23.64% | -3.91 -2.33% | -2.85 27.09% | 0.74 126.15% | 4.35 484.15% | 6.60 51.80% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.63 -23.47% | -0.74 -104.19% | -0.77 -102.39% | -0.83 -50.40% | -0.85 -35.14% | -0.86 -16.96% | -0.65 15.78% | -0.69 16.77% | -0.74 13.10% | -0.81 6.27% |
| Revenue Q2Q % growth | 2.987M 580.41% | 182.141K | 113.332K | 113.332K | 145.717K -95.12% | 145.717K -20.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -47.466M -38.41% | -47.313M -75.48% | -49.98M -45.38% | -51M -15.76% | -52.306M -10.20% | -53.346M -12.75% | -56.018M -12.08% | -57.14M -12.04% | -58.283M -11.43% | -59.446M -11.43% |
| EBIT Q2Q % growth | -44.56M -24.32% | -52.246M -80.02% | -48.941M -40.24% | -54.22M -20.17% | -72.563M -62.84% | -73.083M -39.88% | -56.018M -14.46% | -57.14M -5.39% | -58.283M 19.68% | -59.446M 18.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.55 -400.00% | -0.48 | -0.07 | -15.55% |
| Q1 2025 Q2Q % growth | -0.38 -26.67% | -0.40 | 0.02 | 5.55% |
| Q4 2024 Q2Q % growth | -0.36 -44.00% | -0.46 | 0.10 | 22.57% |
| Q3 2024 Q2Q % growth | -0.51 -104.00% | -0.33 | -0.18 | -52.65% |
| Q2 2024 Q2Q % growth | -0.11 73.81% | -0.32 | 0.21 | 65.71% |
| Q1 2024 Q2Q % growth | -0.30 28.57% | -0.34 | 0.04 | 11.21% |
| Q4 2023 Q2Q % growth | -0.25 35.90% | -0.40 | 0.15 | 37.59% |
| Q3 2023 Q2Q % growth | -0.25 37.50% | -0.48 | 0.23 | 47.85% |
| Q2 2023 Q2Q % growth | -0.42 -2.44% | -0.53 | 0.11 | 20.43% |
| Q1 2023 Q2Q % growth | -0.42 -31.25% | -0.50 | 0.08 | 16.27% |
| Q4 2022 Q2Q % growth | -0.39 -18.18% | -0.50 | 0.11 | 21.41% |
| Q3 2022 Q2Q % growth | -0.40 -53.85% | -0.50 | 0.10 | 19.47% |
| Q2 2022 Q2Q % growth | -0.41 33.87% | -0.38 | -0.03 | -8.25% |
| Q1 2022 Q2Q % growth | -0.32 | -0.38 | 0.06 | 14.75% |
| Q4 2021 Q2Q % growth | -0.33 | -0.31 | -0.02 | -5.27% |
| Q3 2021 Q2Q % growth | -0.26 | -0.18 | -0.08 | -44.28% |
| Q2 2021 Q2Q % growth | -0.62 | -0.13 | -0.49 | -367.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 573.75K | -573.75K | -100.00% |
| Q4 2024 Q2Q % growth | -100.00% | 456.215K | -456.215K | -100.00% |
| Q3 2024 Q2Q % growth | 439K -82.56% | 1.674M | -1.235M | -73.78% |
| Q2 2024 Q2Q % growth | 8.897M 741.72% | 782.789K | 8.114M | 1,036.58% |
| Q1 2024 Q2Q % growth | 1.252M -38.87% | 778.648K | 473.352K | 60.79% |
| Q4 2023 Q2Q % growth | 2.461M -13.65% | 754.035K | 1.707M | 226.38% |
| Q3 2023 Q2Q % growth | 2.517M 39.06% | 862.41K | 1.655M | 191.86% |
| Q2 2023 Q2Q % growth | 1.057M -55.40% | 892.5K | 164.5K | 18.43% |
| Q1 2023 Q2Q % growth | 2.048M 28.81% | 685.695K | 1.362M | 198.68% |
| Q4 2022 Q2Q % growth | 2.85M 75.93% | 808.095K | 2.042M | 252.68% |
| Q3 2022 Q2Q % growth | 1.81M 56.03% | 758.197K | 1.052M | 138.72% |
| Q2 2022 Q2Q % growth | 2.37M 393.75% | 863.603K | 1.506M | 174.43% |
| Q1 2022 Q2Q % growth | 1.59M 318.42% | 834.697K | 755.303K | 90.49% |
| Q4 2021 Q2Q % growth | 1.62M | 441.997K | 1.178M | 266.52% |
| Q3 2021 Q2Q % growth | 1.16M | 135.997K | 1.024M | 752.96% |
| Q2 2021 Q2Q % growth | 480K | 204K | 276K | 135.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.44% | -14.53% | -0.56% | -11.68% |
| Revenue | 17.14% | 1461.83% | 24.21% | 545.01% |